MCP-1 (CCL2) (mouse) ELISA

Monocyte Chemoattractant Protein-1 (MCP-1): Overview and Clinical Implications

Introduction: Monocyte Chemoattractant Protein-1 (MCP-1), also known as CCL2, is a chemokine with critical roles in immune cell recruitment and inflammation. Initially identified for its ability to attract monocytes, MCP-1 also influences the migration of other immune cells, including T lymphocytes and natural killer (NK) cells.

Functions and Expression:

1. Chemotactic Activity:
• Monocytes: MCP-1 is a potent chemoattractant for monocytes, directing their migration to sites of inflammation or injury.
• T Lymphocytes and NK Cells: Besides monocytes, MCP-1 attracts T lymphocytes (both CD4+ and CD8+ subtypes) and NK cells, expanding its role in immune responses.
2. Cellular Sources:
• Macrophages: Predominantly expressed by macrophages in response to pro-inflammatory cytokines like IL-6, TNF-alpha, and IL-1beta.
• Other Cells: Also produced by fibroblasts, endothelial cells, and certain tumor cells under specific stimuli, reflecting its broad impact on various cell types and tissues.

Pathophysiological Roles:

1. Inflammatory Diseases:
• Atherosclerosis: MCP-1 contributes to the accumulation of monocytes in atherosclerotic plaques, influencing plaque development and instability.
• Rheumatoid Arthritis: Elevated MCP-1 levels are associated with the recruitment of monocytes to the synovial tissue, playing a role in joint inflammation and damage.
• Allergic Reactions: Involved in the recruitment of immune cells to allergic sites, exacerbating allergic responses.
2. Basophils:
• Histamine Release: MCP-1 stimulates basophils to release histamine, although its chemotactic activity for basophils is weak compared to its effects on monocytes.

Clinical Implications:

1. Disease Marker:
• Diagnostic and Prognostic Utility: Elevated MCP-1 levels are often found in various inflammatory and autoimmune diseases, making it a potential biomarker for disease activity and progression.
2. Therapeutic Target:
• Drug Development: Given its role in inflammatory diseases, MCP-1 is a potential target for therapeutic interventions aimed at modulating immune cell recruitment and activity. Inhibitors or antagonists of MCP-1 or its receptor (CCR2) may provide therapeutic benefits in managing chronic inflammatory conditions.

Conclusion: MCP-1 is a key chemokine involved in the recruitment of monocytes, T lymphocytes, and NK cells, with significant implications for inflammatory and autoimmune diseases. Its broad expression across various cell types and tissues, coupled with its role in pathological conditions, underscores its importance as both a biomarker and a therapeutic target. Understanding MCP-1's functions and mechanisms can aid in developing targeted treatments for a range of inflammatory and immune-mediated disorders.

This ELISA Kit from Tecan IBL International is for research use only.

Tecan IBL International offers a comprehensive range of ELISAs, immunoassays, antibodies and recombinant proteins.
Explore the full range >